Suprefact Depot
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Buserelin acetate 6.6mg equivalent to 6.3 mg of buserelin
Disponibbli minn:
sanofi-aventis new zealand limited
INN (Isem Internazzjonali):
Buserelin acetate 6.6 mg (equivalent to 6.3 mg of buserelin)
Dożaġġ:
6.3 mg
Għamla farmaċewtika:
Subcutaneous implant
Kompożizzjoni:
Active: Buserelin acetate 6.6mg equivalent to 6.3 mg of buserelin Excipient: Polyglactin
Unitajiet fil-pakkett:
Bag, plastic, trilaminate, 1 implant
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Sanofi-Aventis Deutschland GmbH
Sommarju tal-prodott:
Package - Contents - Shelf Life: Bag, plastic, trilaminate - 1 implants - 3 years from date of manufacture stored at or below 30°C
Data ta 'l-awtorizzazzjoni:
1998-10-22
